Palisade Capital Management’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-582,640
Closed -$13.8M 573
2015
Q4
$13.8M Sell
582,640
-466,815
-44% -$10.9M 0.45% 60
2015
Q3
$21M Buy
1,049,455
+21,311
+2% +$426K 0.62% 29
2015
Q2
$19.9M Sell
1,028,144
-21,227
-2% -$440K 0.51% 47
2015
Q1
$23.8M Buy
1,049,371
+2,970
+0.3% +$68.2K 0.6% 34
2014
Q4
$22.5M Sell
1,046,401
-32,654
-3% -$696K 0.55% 38
2014
Q3
$21.8M Buy
1,079,055
+939
+0.1% +$20.4K 0.55% 36
2014
Q2
$23.5M Sell
1,078,116
-3,809
-0.4% -$80.9K 0.57% 30
2014
Q1
$22.2M Buy
1,081,925
+112,889
+12% +$2.23M 0.54% 37
2013
Q4
$17.6M Buy
969,036
+19,651
+2% +$372K 0.46% 63
2013
Q3
$17.6M Sell
949,385
-1,470
-0.2% -$28.9K 0.48% 61
2013
Q2
$19.2M Buy
+950,855
New +$20.6M 0.55% 35

Other funds holding BMR

Palisade Capital Management's BMR Position: Q1 2016 in Review

Palisade Capital Management sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 582,640 shares — an estimated $13.8M sold.

Palisade Capital Management first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $23.8M in Q1 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Palisade Capital Management reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Palisade Capital Management sold 582,640 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $13.8M.
  • Palisade Capital Management first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Palisade Capital Management's BIOMED REALTY TRUST INC position peaked at $23.8M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Palisade Capital Management's 13F filing for Q1 2016, filed 11 May 2016.